Eli Lilly Bolsters Neuroscience Pipeline With AtaiBeckley Purchase

By Adam Feuerstein · STAT News · 2026-07-16

According to reporting from STAT News, Eli Lilly is moving to acquire AtaiBeckley in a deal valued at $2.8 billion upfront. The pharmaceutical leader intends to utilize the biotechnology firm's research into psychedelic-based mental health therapies to broaden its reach within th

According to reporting from STAT News, Eli Lilly is moving to acquire AtaiBeckley in a deal valued at $2.8 billion upfront. The pharmaceutical leader intends to utilize the biotechnology firm's research into psychedelic-based mental health therapies to broaden its reach within th